Skip to main content
PLOS One logoLink to PLOS One
. 2016 Jun 2;11(6):e0157094. doi: 10.1371/journal.pone.0157094

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K Gupta; DART Virology Group
PMCID: PMC4890937  PMID: 27254277

The title of this article should include “HIV-1.” The correct title is: Evidence for Reduced HIV-1 Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. The correct citation is: Sutherland KA, Parry CM, McCormick A, Kapaata A, Lyagoba F, Kaleebu P, et al. (2015) Evidence for Reduced HIV-1 Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS ONE 10(9): e0137834. doi:10.1371/journal.pone.0137834.

Reference

  • 1.Sutherland KA, Parry CM, McCormick A, Kapaata A, Lyagoba F, Kaleebu P, et al. (2015) Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS ONE 10(9): e0137834 doi:10.1371/journal.pone.0137834 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES